Literature DB >> 9514735

Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA.

D Fourmy1, M I Recht, J D Puglisi.   

Abstract

Aminoglycoside antibiotics that bind to ribosomal RNA in the aminoacyl-tRNA site (A-site) cause misreading of the genetic code and inhibit translocation. We have recently solved the structure of an A-site RNA-paromomycin complex. The structure suggested that rings I and II, common to all aminoglycosides that bind to the A-site, are the minimum motif for specific ribosome binding to affect translation. This hypothesis was tested biochemically and with a detailed comparative NMR study of interaction of the aminoglycosides paromomycin, neomycin, ribostamycin, and neamine with the A-site RNA. Our NMR data show that rings I and II of neomycin-class aminoglycosides are sufficient to confer specificity to the binding of the antibiotics to the model A-site RNA. Neomycin, paromomycin, ribostamycin and neamine bind in the major groove of the A-site RNA in a unique binding pocket formed by non-canonical base pairs and a bulged nucleotide. Similar NMR properties of the RNA and the diverse antibiotics within the different complexes formed with neomycin, paromomycin, ribostamycin and neamine suggest similar structures for these complexes. Copyright 1998 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514735     DOI: 10.1006/jmbi.1997.1552

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  55 in total

Review 1.  Correction of genetic disease by making sense from nonsense.

Authors:  R J Kaufman
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 2.  Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance.

Authors:  L P Kotra; J Haddad; S Mobashery
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

3.  NMR structure of a ribosomal RNA hairpin containing a conserved CUCAA pentaloop.

Authors:  U Nagaswamy; X Gao; S A Martinis; G E Fox
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

4.  A modified fluorescent intercalator displacement assay for RNA ligand discovery.

Authors:  Papa Nii Asare-Okai; Christine S Chow
Journal:  Anal Biochem       Date:  2010-09-21       Impact factor: 3.365

5.  A Hybrid Drug Limits Resistance by Evading the Action of the Multiple Antibiotic Resistance Pathway.

Authors:  Kathy K Wang; Laura K Stone; Tami D Lieberman; Michal Shavit; Timor Baasov; Roy Kishony
Journal:  Mol Biol Evol       Date:  2015-11-03       Impact factor: 16.240

6.  Mechanism of action of a novel series of naphthyridine-type ribosome inhibitors: enhancement of tRNA footprinting at the decoding site of 16S rRNA.

Authors:  Linus L Shen; Candace Black-Schaefer; Yingna Cai; Peter J Dandliker; Bruce A Beutel
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

7.  Screening for engineered neomycin riboswitches that control translation initiation.

Authors:  Julia E Weigand; Martin Sanchez; Ewald-Bernd Gunnesch; Sabrina Zeiher; Renee Schroeder; Beatrix Suess
Journal:  RNA       Date:  2007-11-13       Impact factor: 4.942

8.  Synthesis and antibacterial activity of pyranmycin derivatives with N-1 and O-6 modifications.

Authors:  Jie Li; Fang-I Chiang; Hsiao-Nung Chen; Cheng-Wei Tom Chang
Journal:  Bioorg Med Chem       Date:  2007-09-01       Impact factor: 3.641

9.  Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.

Authors:  Jun-ichi Wachino; Keigo Shibayama; Hiroshi Kurokawa; Kouji Kimura; Kunikazu Yamane; Satowa Suzuki; Naohiro Shibata; Yasuyoshi Ike; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

10.  Structural origins of gentamicin antibiotic action.

Authors:  S Yoshizawa; D Fourmy; J D Puglisi
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.